Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
T Cell Types and Functions01:24

T Cell Types and Functions

2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Gut dysbiosis from high-salt diet promotes glioma via propionate-mediated TGF-β activation.

The Journal of experimental medicine·2025
Same author

Differential responses of lung and intestinal microbiota to SARS-CoV-2 infection: a comparative study of the Wuhan and Omicron strains in K18-hACE2 Tg mice.

Laboratory animal research·2025
Same author

Inhibitory Fcγ receptor deletion enhances CD8 T cell stemness increasing anti-PD-1 therapy responsiveness against glioblastoma.

Journal for immunotherapy of cancer·2024
Same author

Assessment of immunopathological responses of a novel non-chemical biocide in C57BL/6 for safe disinfection usage.

Laboratory animal research·2024
Same author

Double-edged sword: γδ T cells in mucosal homeostasis and disease.

Experimental & molecular medicine·2023
Same author

Regulation of c-SMAC formation and AKT-mTOR signaling by the TSG101-IFT20 axis in CD4<sup>+</sup> T cells.

Cellular & molecular immunology·2023

相关实验视频

Updated: Jan 11, 2026

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
06:29

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Published on: May 5, 2023

3.0K

解锁IL-33:对瘤免疫的新见解

Byeong Hoon Kang1,2, Heung Kyu Lee2

  • 1Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea.

Immune network
|November 12, 2025
PubMed
概括
此摘要是机器生成的。

介素-33 (IL-33) 是一种警示剂,在瘤微环境中具有双重作用,影响瘤生长和免疫反应. 这篇评论探讨了IL-33的研究.

关键词:
癌症免疫疗法癌症免疫疗法这里有IL-33和IL-33.瘤微环境是一个微环境.第1类免疫的免疫力第二类免疫的免疫力.

更多相关视频

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
07:49

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

20.8K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.8K

相关实验视频

Last Updated: Jan 11, 2026

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
06:29

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Published on: May 5, 2023

3.0K
Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
07:49

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

20.8K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.8K

科学领域:

  • 免疫学 免疫学 免疫学
  • 癌症生物学 癌症生物学
  • 分子生物学分子生物学

背景情况:

  • 介质素-33 (IL-33) 是一种IL-1家族的细胞因子,在细胞核中构成性表达.
  • 在组织损伤时释放,IL-33充当警报剂,通过其受体ST2.2.激活免疫细胞.
  • 在介导1型和2型免疫的免疫细胞上的ST2表达突显了IL-33的性作用.

研究的目的:

  • 要总结IL-33.3的免疫功能.
  • 强调IL-33在瘤免疫和瘤微环境 (TME) 中的复杂作用.
  • 审查基于IL-33的癌症免疫疗法的进展.

主要方法:

  • 对IL-33.3现有研究的文献综述.
  • 分析IL-33在各种免疫反应中的功能.
  • 评估IL-33对TME和癌症进展的影响.

主要成果:

  • IL-33在TME中表现出双重作用,可能促进或抑制瘤的发展.
  • IL-33 影响各种免疫细胞,有助于前瘤和抗瘤反应.
  • 最近的研究强调IL-33在癌症免疫治疗策略中的潜力.

结论:

  • IL-33是瘤免疫的重要因素,具有复杂的,取决于环境的影响.
  • 准IL-33为新型癌症疗法提供了一个有希望的途径.
  • 进一步研究IL-33在TME中的机制可以优化其治疗应用.